Dave C Morris | Vice President Of Therapeutic Discovery
Precision BioSciences

Dave C Morris, Vice President Of Therapeutic Discovery, Precision BioSciences

Dave Morris, PhD, is Vice President of Therapeutic Discovery at Precision BioSciences where he leads a team focused on the pharmacological profiling of ARCUS nucleases developed for specific genetic targets. With over 15 years of experience leading multi-disciplinary international line and matrix-research teams in the US and UK/Europe, his drug discovery experience includes all stages from target identification to clinical candidate selection. Dr. Morris has previously led research and drug discovery programs at the University of North Carolina Eshelman School of Pharmacy and GlaxoSmithKline, where he specialized in target and hit discovery, lead optimization, and technology evaluation, development, and implementation. He earned his PhD in cell biology and ultrastructural anatomy at the University of Liverpool with a specialization in biomineralization and the role of extracellular vesicles.

Appearances:



Conference Day 1 - Tuesday 31st March 2020 @ 17:00

Targeted Elimination of viral DNA using ARCUS gene editing

last published: 06/Dec/19 09:35 GMT

back to speakers